Literature DB >> 23020535

Diagnostic values of metabolic syndrome definitions for detection of insulin resistance: Tehran Lipid and Glucose Study (TLGS).

Farhad Hosseinpanah1, Shiva Borzooei, Maryam Barzin, Marjan Farshadi, Farzaneh Sarvghadi, Fereidoun Azizi.   

Abstract

BACKGROUND: This study examines the characteristics and agreement between different definitions of metabolic syndrome (MetS) and insulin resistance (IR).
METHODS: A total of 347 non-diabetic individuals who were ≥ 20 years of age were selected from the Tehran Lipid and Glucose Study (TLGS). Subjects were categorized as having MetS by the Adult Treatment Panel III (ATP III) and the Joint Interim Statement (JIS). IR was estimated by using the homeostasis model assessment (HOMA-IR).
RESULTS: According to ATP III and JIS criteria 38.9% and 38.2% of subjects had MetS respectively. The sensitivity of ATP III was 52.3% and specificity was 65%; for JIS the sensitivity was 52.3%, with a specificity of 66.5%. Kappa between ATP III or JIS and HOMA-IR was 0.14 and 0.16, respectively. Based on receiver operating characteristic (ROC) analysis, the use of waist circumference (WC) and fasting plasma glucose (FPG) for the diagnosis of IR in women showed a diagnostic accuracy equal to or instead of counting MetS components using modified ATP III or JIS. WC optimal cut points for prediction of IR were 93.5 cm for men and 92.5 cm for women.
CONCLUSIONS: ATP III and JIS definitions have low sensitivities and specificities for detecting IR. There is poor agreement between these criteria and IR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020535     DOI: 0121510/AIM.006

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  6 in total

1.  Predictors of the incident metabolic syndrome in healthy obese subjects: a decade of follow-up from the Tehran Lipid and Glucose Study.

Authors:  F Hosseinpanah; P Nazeri; S Ghareh; M Tohidi; F Azizi
Journal:  Eur J Clin Nutr       Date:  2013-08-21       Impact factor: 4.016

2.  Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study.

Authors:  R Eshtiaghi; S Keihani; F Hosseinpanah; M Barzin; F Azizi
Journal:  Int J Obes (Lond)       Date:  2014-10-07       Impact factor: 5.095

Review 3.  Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis.

Authors:  Azad Fatahi; Amin Doosti-Irani; Zahra Cheraghi
Journal:  Int J Prev Med       Date:  2020-06-03

Review 4.  Metabolic Syndrome: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Firoozeh Hosseini-Esfahani; Zahra Bahadoran; Nazanin Moslehi; Golaleh Asghari; Emad Yuzbashian; Somayeh Hosseinpour-Niazi; Parvin Mirmiran; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2018-10-21

5.  The positive effect of short-term nano-curcumin therapy on insulin resistance and serum levels of afamin in patients with metabolic syndrome.

Authors:  Nejat Kheiripour; Zahra Khodamoradi; Akram Ranjbar; Shiva Borzouei
Journal:  Avicenna J Phytomed       Date:  2021 Mar-Apr

Review 6.  Pivotal role of microRNA-33 in metabolic syndrome: A systematic review.

Authors:  Mojgan Gharipour; Masoumeh Sadeghi
Journal:  ARYA Atheroscler       Date:  2013-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.